The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term trastuzumab safety in tailored dose-dense anthracycline containing adjuvant chemotherapy in the PANTHER phase III trial.
 
Andri Papakonstantinou
No Relationships to Disclose
 
Mats Hellström
No Relationships to Disclose
 
Anne Andersson
No Relationships to Disclose
 
Per Malmstrom
Patents, Royalties, Other Intellectual Property - Participation in royalty sharing agreements PFS Genomics United States
 
Jonas Bergh
Leadership - Asklepios Medicin HB; Coronis and Asklepios Cancer Research AB
Stock and Other Ownership Interests - Stratipath AB
Honoraria - AstraZeneca; Novartis; Roche
Research Funding - Amgen (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - UpToDate
 
Theodoros Foukakis
Honoraria - UpToDate
Research Funding - AstraZeneca (Inst); Novartis (Inst); Veracyte (Inst)